ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2568

Involvement Of Collagen-Binding Heat Shock Protein 47 In The Scleroderma-Associated Fibrosis

Haiyan Chu1, Ting Wu1, Wenyu Wu2, Wenzhen Tu3, Yanyun Ma1, Qingmei Liu1, Hejian Zou4, Li Jin1 and Jiu-Cun Wang1, 1Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai, China, 2Division of Dermatology, Division of Dermatology, Huashan Hospital, Fudan University, Shanghai, Shanghai, China, 3Medicine, Shanghai Traditional Chinese Medicine-Integrated Hospital, Shang hai, China, 4Rheumatology, Huashan Hospital, Shanghai, China

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Collagen, Fibroblasts, heat-shock proteins and scleroderma

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Scleroderma or systemic sclerosis (SSc) is characterized by the fibrosis of skin and visceral organs, especially the uncontrolled fibrosis of multiple organs. Collagen is a major extracellular matrix (ECM) protein that deposited in the fibrotic organs. Heat shock protein 47 (HSP47) has been identified as a collagen-specific chaperon, and plays an important role in the development of fibrosis. Our previous study demonstrated that HSP47 was significantly up-regulated in the skin of dermal sclerosis mice induced by bleomycin. The aim of the present study is to investigate the role of HSP47 in the pathogenesis of scleroderma.

Methods:

For in vivo studies, C57BL/6 female mice of 6-8 weeks (n = 5 for each treatment) were injected with bleomycin subcutaneously into the same site of the shaved upper back daily for 3 weeks. The mRNA and protein level of HSP47 in the lesion skins from the mouse model was assessed by real-time PCR and western blot. In clinical study, skin biopsies and fibroblasts, peripheral blood mononuclear cells (PBMC) and plasma of SSc patients were obtained to study the role of HSP47 during the pathogenesis of SSc. Immunohistochemical staining was performed to identify the localization of HSP47 in the skin of SSc patients, real-time PCR and western blot were conducted to respectively test the gene and protein expression levels of HSP47 in the skin fibroblasts, and ELISA was used to detect the protein level of HSP47 in the plasma of SSc patients. For in vitro study, silencing and over-expression of HSP47 in NIH/3T3 fibroblast cells were performed using HSP47 siRNA and HSP47 expression plasmid respectively to investigate the effect of HSP47 on collagen production.

Results:

For in vivo study, HSP47 was significantly up-regulated in the skin lesion of the mice treated by bleomycin. Meanwhile, the expression of α-SMA increased in the skin lesion of the mice in response to bleomycin. In clinical study, the level of HSP47 increased in the fibroblasts cultured from SSc patients’ skin, the number of HSP47 positive cells increased in the skin of SSc patients, and the localization of HSP47-positive cells were observed in accordance with the α-SMA-positive cells. Additionally, the protein level of HSP47 in the plasma and the mRNA level of HSP47 in the peripheral blood mononuclear cells were both elevated in the SSc samples. In vitrostudy found that over-expression of HSP47 in the fibroblasts increased the level of collagen, whereas knockdown of HSP47 gene decreased its expression.

Conclusion: The production of collagen is affected by HSP47, and HSP47 might be involved in the pathogenesis of scleroderma. Further investigations may be necessary to test this collagen chaperone as an important therapeutic approach.


Disclosure:

H. Chu,
None;

T. Wu,
None;

W. Wu,
None;

W. Tu,
None;

Y. Ma,
None;

Q. Liu,
None;

H. Zou,
None;

L. Jin,
None;

J. C. Wang,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/involvement-of-collagen-binding-heat-shock-protein-47-in-the-scleroderma-associated-fibrosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology